Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Dec
2
2014
Health Care Law Update - December 1, 2014 Mintz
Feb
20
2015
Deja Vu All Over Again: Federal GMO Labeling Legislation Re-Introduced Mintz
Apr
9
2015
Massachusetts Announces Significant Changes to the Medical Marijuana Dispensary Program Mintz
Sep
29
2022
MintzRx — Drug Pricing Update: The Inflation Reduction Act Mintz
Aug
29
2019
Telemedicine Platform Recalled Over Failure to Obtain Pre-Market Clearance or Approval from FDA Mintz
Jul
29
2015
Emerging State Biosimilar Laws – Reference Chart and Five Issues to Watch Mintz
Aug
26
2015
State Pharmaceutical Pricing Disclosure Laws: Old Story, New Refrain Mintz
Feb
3
2023
Bankruptcy Court Finds Cannabis Employee Not Entitled to Chapter 13 Protection Mintz
Jan
16
2020
Regulatory Agencies Launch Unified Website for Biotechnology Regulation Mintz
Feb
10
2016
First Monoclonal Antibody Biosimilar in U.S. Gets One Step Closer to FDA Approval Mintz
Jan
23
2020
Growing Number of States Enact Drug Pricing Transparency Laws Mintz
Feb
4
2020
New Government Action Aims to Increase Competition among Biological Products: FDA and FTC Step Up Industry Pressure Mintz
May
12
2016
Just as Comment Period for “Natural” Ends, FDA Announces Intent to Re-Examine What It Means to Be a “Healthy” Food Mintz
Aug
31
2016
FDA Approves Third Biosimilar Product Mintz
Nov
9
2023
Connecticut Law Imposes New Requirements on Pharmaceutical Manufacturers, Defined to Include Device and Cosmetic Manufacturers, that Employ “Pharmaceutical Sales Representatives” Mintz
Dec
20
2023
Boosting Biotech: New York City Revives Tax Credits for Emerging Companies Mintz
Aug
6
2020
FDA Greenlights Updates to the Purple Book Database Mintz
Oct
5
2020
California Becomes First State to Ban 24 Ingredients from Cosmetics and Personal Care Products Mintz
Mar
7
2024
Health Law Diagnosed – A Discussion on the Regulatory Requirements for LDTs [Podcast] Mintz
Mar
7
2012
New FDA Research Consent Form Requirements – Effective Today Mintz
May
28
2012
Revised Draft Regulations Postpone Compliance with California’s Nonresidential Building Energy Use Disclosure Program Mintz
Jan
21
2013
Energy & Clean Tech Connections – January 2013 Edition Mintz
May
15
2013
Energy & Environmental Law Update May 13, 2013 Mintz
May
12
2021
Health Law Diagnosed — Hot Topics in FDA Regulation and Enforcement [PODCAST] Mintz
Jun
4
2013
Farm Bill Amendments, Presidential Nominees, and the Shaheen-Portman Energy Efficiency Bill Mintz
May
14
2018
President Trump Delivers Much Anticipated Drug Pricing Speech Mintz
Jul
16
2013
The House Takes Action on Energy Legislation, and Senate Leader Forces Vote on Presidential Nominations Mintz
Oct
24
2013
National Institute of Standards and Technology (NIST) Publishes Preliminary Federal Cybersecurity “Framework” for Comment Mintz
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins